You are here

Company Monitoring Page for CSL

latest headlines for company on cafepharma

CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb

Endpoints

Thu, 06/9/22 - 10:23 am

Tags:

CSL, Seqirus, drug manufacturing, North Carolina

The top 10 biopharma M&A deals in 2021

Fierce Pharma

Tue, 01/18/22 - 10:53 am

Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing

Endpoints

Thu, 12/16/21 - 11:53 pm

Tags:

Vifor Pharma, CSL, M&A

Biopharma’s buyout year ends with a bang

EP Vantage

Wed, 12/15/21 - 10:37 am

Tags:

M&A, CSL, Vifor Pharma, Pfizer, Arena Pharmaceuticals

As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report

Endpoints

Mon, 12/13/21 - 11:02 am

Tags:

M&A, Vifor Pharma, CSL

Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says

Fierce Pharma

Wed, 08/25/21 - 09:32 pm

Tags:

Takeda, CSL, hereditary angiodema, HAE, RWE, Takhzyro, Cinryze, Haegarda

UniQure/CSL hit by FDA clinical hold for hem B gene therapy program after liver cancer find

Fierce Biotech

Mon, 12/21/20 - 11:09 am

Tags:

uniQure, CSL, FDA, clinical trials, hemophilia B, gene therapy, etranacogene dezaparvovec

Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE

Endpoints

Wed, 11/18/20 - 11:07 pm

Tags:

Pharvaris, HAE, Takeda, CSL

Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL

BioPharma Dive

Sat, 10/10/20 - 11:27 pm

Tags:

clinical trials, plasma, COVID-19, Takeda, CSL

UniQure out-licenses hemophilia B gene therapy in deal valued up to ~$2.1B

Seeking Alpha

Wed, 06/24/20 - 11:29 pm

Tags:

uniQure, CSL, hemophilia B, etranacogene dezaparvovec

Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process

BioPharma Dive

Wed, 04/8/20 - 10:33 am

Tags:

Takeda, CSL, COVID-19, plasma, drug development

Want to win over payers, pharma? Forget the 'me-too' drugs, CSL chief says

Fierce Pharma

Tue, 01/15/19 - 11:06 am

Tags:

CSL, Paul Perreault, me-too drugs, payers

Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL

Fierce Pharma

Thu, 06/21/18 - 12:02 pm

Tags:

CSL, HAE, Shire, Cinryze, Haegarda

CSL revamps branding to recruit employees, partners

Fierce Pharma

Mon, 03/5/18 - 03:01 pm

Tags:

CSL snags a preclinical stem cell therapy in $416M Calimmune buyout

Endpoints

Mon, 08/28/17 - 09:29 am

Tags:

CSL, Calimmune, M&A, stem cells

FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire

Endpoints

Fri, 06/23/17 - 09:48 am

Tags:

FDA, CSL, HAE, hereditary angiodema, Shire, Haegarda, Firazyr, Kalbito

Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch

Fierce Pharma

Mon, 04/17/17 - 04:10 pm

Tags:

Shire, rare disease, CSL, patents, Haegarda, HAE, hereditary angiodema

Hemophilia marketing tactics raise questions as market heats up

Fierce Pharma

Thu, 01/14/16 - 08:47 pm

Tags:

hemophilia, drug marketing, Biogen, CSL, Bayer, Roche

First flu vaccine with immune-boosting adjuvant approved for US market

Stat

Wed, 11/25/15 - 11:35 am

Tags:

flu vaccines, vaccines, immune-boosting adjuvants, Fluad, CSL, Novartis, Seqirus

How Does Novavax Compare to Its Competitors?

Yahoo/Market Realist

Mon, 08/31/15 - 11:18 am

Tags:

Novavax, Inovio, iBio, CSL, Sinovac, Biota

Pages

last 30 twitter posts